(ZWS) Zurn Elkay Water Solutions - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US98983L1089

Water Dispensers, Filtration, Safety Valves, Sinks, Flush Valves

Dividends

Dividend Yield 0.81%
Yield on Cost 5y 2.21%
Yield CAGR 5y 1.74%
Payout Consistency 69.4%
Payout Ratio 25.7%
Risk via 10d forecast
Volatility 26.0%
Value at Risk 5%th 39.3%
Relative Tail Risk -8.04%
Reward TTM
Sharpe Ratio 0.57
Alpha 3.66
CAGR/Max DD 1.02
Character TTM
Hurst Exponent 0.610
Beta 0.889
Beta Downside 0.983
Drawdowns 3y
Max DD 30.18%
Mean DD 6.47%
Median DD 4.96%

Description: ZWS Zurn Elkay Water Solutions November 06, 2025

Zurn Elkay Water Solutions Corp. (NYSE: ZWS) designs, manufactures, and markets a broad portfolio of water-management products-including filtered drinking stations, backflow preventers, PEX piping, commercial faucets, sinks, restroom partitions, and sensor-operated flush valves-under the Elkay, Zurn, Wilkins, Green Turtle, and related brands. Its customers span institutional, commercial, water-works, and residential markets, reached through independent reps, plumbing wholesalers, and specialty distributors.

Key recent metrics: the company reported FY 2024 revenue of $1.84 billion, a 5.2% year-over-year increase driven by strong demand for water-conservation fixtures amid tightening building-code standards. Gross margin held at 38.6%, reflecting pricing power in the premium-segment plumbing market. A notable sector driver is the U.S. “green building” trend, with LEED-certified projects expected to boost demand for low-flow and sensor-based fixtures by an estimated 3-4% annually through 2028.

For a deeper, data-rich assessment of ZWS’s valuation dynamics, you may find ValueRay’s analyst toolkit useful for drilling into forward-looking cash-flow scenarios and peer-group benchmarks.

Piotroski VR‑10 (Strict, 0-10) 7.0

Net Income (193.3m TTM) > 0 and > 6% of Revenue (6% = 99.6m TTM)
FCFTA 0.11 (>2.0%) and ΔFCFTA 0.77pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 30.88% (prev 30.65%; Δ 0.23pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.12 (>3.0%) and CFO 318.4m > Net Income 193.3m (YES >=105%, WARN >=100%)
Net Debt (236.3m) to EBITDA (358.1m) ratio: 0.66 <= 3.0 (WARN <= 3.5)
Current Ratio 2.78 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (170.3m) change vs 12m ago -1.59% (target <= -2.0% for YES)
Gross Margin 44.91% (prev 45.20%; Δ -0.29pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 61.59% (prev 57.40%; Δ 4.19pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 9.31 (EBITDA TTM 358.1m / Interest Expense TTM 29.6m) >= 6 (WARN >= 3)

Altman Z'' -0.56

(A) 0.19 = (Total Current Assets 800.7m - Total Current Liabilities 288.2m) / Total Assets 2.68b
(B) -0.43 = Retained Earnings (Balance) -1.15b / Total Assets 2.68b
(C) 0.10 = EBIT TTM 275.5m / Avg Total Assets 2.69b
(D) -1.05 = Book Value of Equity -1.15b / Total Liabilities 1.09b
Total Rating: -0.56 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 74.79

1. Piotroski 7.0pt
2. FCF Yield 3.48%
3. FCF Margin 17.39%
4. Debt/Equity 0.35
5. Debt/Ebitda 0.66
6. ROIC - WACC (= 1.40)%
7. RoE 12.29%
8. Rev. Trend 76.38%
9. EPS Trend 71.84%

What is the price of ZWS shares?

As of December 13, 2025, the stock is trading at USD 47.14 with a total of 758,376 shares traded.
Over the past week, the price has changed by +0.60%, over one month by -0.54%, over three months by +1.23% and over the past year by +18.93%.

Is ZWS a buy, sell or hold?

Zurn Elkay Water Solutions has received a consensus analysts rating of 3.75. Therefor, it is recommend to hold ZWS.
  • Strong Buy: 3
  • Buy: 0
  • Hold: 5
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the ZWS price?

Issuer Target Up/Down from current
Wallstreet Target Price 50.3 6.7%
Analysts Target Price 50.3 6.7%
ValueRay Target Price 56.5 19.8%

ZWS Fundamental Data Overview December 03, 2025

Market Cap USD = 8.00b (8.00b USD * 1.0 USD.USD)
P/E Trailing = 43.7982
P/E Forward = 28.9017
P/S = 4.8204
P/B = 5.0158
P/EG = 1.9273
Beta = 0.827
Revenue TTM = 1.66b USD
EBIT TTM = 275.5m USD
EBITDA TTM = 358.1m USD
Long Term Debt = 495.5m USD (from longTermDebt, last quarter)
Short Term Debt = 900.0k USD (from shortLongTermDebt, last quarter)
Debt = 551.6m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 236.3m USD (from netDebt column, last quarter)
Enterprise Value = 8.29b USD (8.00b + Debt 551.6m - CCE 260.1m)
Interest Coverage Ratio = 9.31 (Ebit TTM 275.5m / Interest Expense TTM 29.6m)
FCF Yield = 3.48% (FCF TTM 288.6m / Enterprise Value 8.29b)
FCF Margin = 17.39% (FCF TTM 288.6m / Revenue TTM 1.66b)
Net Margin = 11.65% (Net Income TTM 193.3m / Revenue TTM 1.66b)
Gross Margin = 44.91% ((Revenue TTM 1.66b - Cost of Revenue TTM 914.2m) / Revenue TTM)
Gross Margin QoQ = 44.07% (prev 45.51%)
Tobins Q-Ratio = 3.09 (Enterprise Value 8.29b / Total Assets 2.68b)
Interest Expense / Debt = 1.29% (Interest Expense 7.10m / Debt 551.6m)
Taxrate = 24.34% (19.5m / 80.1m)
NOPAT = 208.4m (EBIT 275.5m * (1 - 24.34%))
Current Ratio = 2.78 (Total Current Assets 800.7m / Total Current Liabilities 288.2m)
Debt / Equity = 0.35 (Debt 551.6m / totalStockholderEquity, last quarter 1.59b)
Debt / EBITDA = 0.66 (Net Debt 236.3m / EBITDA 358.1m)
Debt / FCF = 0.82 (Net Debt 236.3m / FCF TTM 288.6m)
Total Stockholder Equity = 1.57b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.20% (Net Income 193.3m / Total Assets 2.68b)
RoE = 12.29% (Net Income TTM 193.3m / Total Stockholder Equity 1.57b)
RoCE = 13.32% (EBIT 275.5m / Capital Employed (Equity 1.57b + L.T.Debt 495.5m))
RoIC = 10.15% (NOPAT 208.4m / Invested Capital 2.05b)
WACC = 8.75% (E(8.00b)/V(8.55b) * Re(9.29%) + D(551.6m)/V(8.55b) * Rd(1.29%) * (1-Tc(0.24)))
Discount Rate = 9.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.60%
[DCF Debug] Terminal Value 75.44% ; FCFE base≈281.2m ; Y1≈310.2m ; Y5≈400.5m
Fair Price DCF = 33.32 (DCF Value 5.58b / Shares Outstanding 167.4m; 5y FCF grow 11.85% → 3.0% )
EPS Correlation: 71.84 | EPS CAGR: 19.57% | SUE: 2.83 | # QB: 8
Revenue Correlation: 76.38 | Revenue CAGR: 19.66% | SUE: 2.10 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.36 | Chg30d=+0.010 | Revisions Net=+2 | Analysts=4
EPS next Year (2026-12-31): EPS=1.65 | Chg30d=+0.073 | Revisions Net=+8 | Growth EPS=+9.6% | Growth Revenue=+5.1%

Additional Sources for ZWS Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle